Alternatives for Reducing Tics in Tourette Syndrome (TS): A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and Adolescents
Public ClinicalTrials.gov record NCT03452943. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and Adolescents
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a study to evaluate the efficacy and safety of deutetrabenazine (TEV-50717) tablets for the reduction of motor and phonic tics associated with TS in children and adolescents 6 through 16 years of age.
Study identification
- NCT ID
- NCT03452943
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 119 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 6 Years to 16 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 5, 2018 (Actual)
- Primary completion
- Nov 12, 2019 (Actual)
- Completion
- Nov 12, 2019 (Actual)
- Last update posted
- Nov 9, 2021
2018 – 2019
United States locations
- U.S. sites
- 27
- U.S. states
- 17
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Teva Investigational Site 046-0104 | Dothan | Alabama | 36303 | — |
| Teva Investigational Site 046-0117 | Sun City | Arizona | 85351 | — |
| Teva Investigational Site 046-0107 | Rogers | Arkansas | 72758 | — |
| Teva Investigational Site 046-0126 | Anaheim | California | 92805 | — |
| Teva Investigational Site 046-0101 | Sacramento | California | 95815 | — |
| Teva Investigational Site 046-0111 | San Diego | California | 92108 | — |
| Teva Investigational Site 046-0130 | Santa Ana | California | 92705 | — |
| Teva Investigational Site 046-0132 | Miami | Florida | 33155 | — |
| Teva Investigational Site 046-0115 | Orlando | Florida | 32803 | — |
| Teva Investigational Site 046-0114 | St. Petersburg | Florida | 33701 | — |
| Teva Investigational Site 046-0116 | Atlanta | Georgia | 30331 | — |
| Teva Investigational Site 046-0133 | Naperville | Illinois | 60563 | — |
| Teva Investigational Site 046-0128 | Boston | Massachusetts | 02114 | — |
| Teva Investigational Site 046-0110 | Saint Charles | Missouri | 63304 | — |
| Teva Investigational Site 046-0134 | Lincoln | Nebraska | 68526-9467 | — |
| Teva Investigational Site 046-0109 | Voorhees Township | New Jersey | 08043 | — |
| Teva Investigational Site 046-0124 | New York | New York | 10029 | — |
| Teva Investigational Site 046-0102 | Rochester | New York | 14618 | — |
| Teva Investigational Site 046-0112 | Rochester | New York | 14642 | — |
| Teva Investigational Site 046-0125 | Raleigh | North Carolina | 27607 | — |
| Teva Investigational Site 046-0106 | Oklahoma City | Oklahoma | 73116 | — |
| Teva Investigational Site 046-0113 | Dallas | Texas | 75243 | — |
| Teva Investigational Site 046-0108 | Houston | Texas | 77030 | — |
| Teva Investigational Site 046-0103 | Houston | Texas | 77090 | — |
| Teva Investigational Site 046-0120 | San Antonio | Texas | 78249 | — |
| Teva Investigational Site 046-0105 | Orem | Utah | 84058 | — |
| Teva Investigational Site 046-0118 | Petersburg | Virginia | 23805 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03452943, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 9, 2021 · Synced Oct 31, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03452943 live on ClinicalTrials.gov.